Cox B-IN-1
Cox B-IN-1 (7a) exhibits antiviral activity against Coxsackievirus B (Cox B) . Cox B-IN-1 (7a) possesses dual activity that inhibits viral adsorption and replication. Cox B-IN-1 (7a) demonstrates substantial potential as an inhibitor of the 3C protease from coxsackievirus[1].
Product Specifications
UNSPSC
12352005
Target
Enterovirus
Related Pathways
Anti-infection
Field of Research
Infection; Inflammation/Immunology
Smiles
CC1=C(SC(N/N=C2C(C=CC=C3)=C3C(/C\2=C/C4=CC(OC)=CC=C4OC)=N\NC5=NC(C)=C(/N=N/C6=CC=CC=C6)S5)=N1)/N=N/C7=CC=CC=C7
Molecular Formula
C38H32N10O2S2
Molecular Weight
724.86
References & Citations
[1]Thoraya A Farghaly, et al. Synthesis, characterization, molecular docking, pharmacokinetics, and molecular dynamics of new bis-thiazoles based on bis-thiosemicarbazone as anti-coxsackievirus. Sci Rep. 2024 Nov 26;14 (1) :29378.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940050-100 1x 100 µL
IgA Secretory Component (SC05), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
